Willow Biosciences (TSE:WLLW) Stock Price Down 25% – Should You Sell?

Shares of Willow Biosciences Inc. (TSE:WLLWGet Free Report) were down 25% on Monday . The company traded as low as C$0.05 and last traded at C$0.06. Approximately 1,357,977 shares traded hands during mid-day trading, an increase of 476% from the average daily volume of 235,723 shares. The stock had previously closed at C$0.08.

Willow Biosciences Trading Down 25.0 %

The firm has a 50-day moving average of C$0.07 and a 200 day moving average of C$0.09. The company has a current ratio of 0.70, a quick ratio of 19.71 and a debt-to-equity ratio of 131.61. The stock has a market capitalization of C$8.65 million, a price-to-earnings ratio of -1.00 and a beta of 1.13.

About Willow Biosciences

(Get Free Report)

Willow Biosciences Inc is a Canadian biotechnology company based in Calgary. It produces high purity, plant-derived compounds that provide building blocks for the global pharmaceutical, health and wellness, and consumer packaged goods industries. Geographically, it derives a majority of revenue from Canada.

Featured Articles

Receive News & Ratings for Willow Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Willow Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.